Full Text
Cost/Benefit Analysis of First Line Chronic Lymphocytic Leukemia (CLL) Treatments in Mexico

Abstract

Authors

E. Wehler V. Leyva D. Bertwistle J. Munakata A. Valencia A. Hernandez L. de la Torre L. Gonzalez

Back to Volume 16, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×